Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

References

• Ances B, Ellis RJ (2007). Dementia and Neurocognitive Disorders Due to HIV-1 Infection. Semin Neurol 27: 86–92.
   PubMed Web of Science ®Google Scholar
• Anthony IC, Bell JE (2008). The Neuropathology of HIV/AIDS. Int Rev Psychiatry 20: 15–24.
   PubMed Web of Science ®Google Scholar
• Arendt GvGH (2002). Antiretroviraltherapy regimes for neuro-AIDS. Curr Drug Targets Infects Disord 2: 187–192.
   PubMedGoogle Scholar
• Bell JE (2004). An update on the neuropathology of HIV in the HAART era. Histopathology 45: 549–559.
   Web of Science ®Google Scholar
• Bell JE, Donaldson YK, Lowrie S, (1996). Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 10: 493–499.
   PubMed Web of Science ®Google Scholar
• Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 58: 721–728.
   PubMed Web of Science ®Google Scholar
• Budka H (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163–175.
   PubMed Web of Science ®Google Scholar
• Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D (1991). HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1: 143–152.
   PubMed Web of Science ®Google Scholar
• Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK (2004). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol 18: 234–248.
   PubMed Web of Science ®Google Scholar
• Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59: 1563–1567.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (2007). HIV/AIDS Surveillance Report, 2005. Atlanta: U.S. Department of Health and Human Services.
   Google Scholar
• Davies J, Everall IP, Weich S, McLaughlin J, Scaravilli F, Lantos PL (1997). HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS 11: 1145–1150.
   PubMed Web of Science ®Google Scholar
• Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9: 209–217.
   PubMed Web of Science ®Google Scholar
• Everall IP, Luthert PJ, Lantos PL (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119–1121.
   PubMed Web of Science ®Google Scholar
• Everall IP, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E (2006). Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology 67: 1867–1869.
   PubMed Web of Science ®Google Scholar
• Gibbs JE, Gaffen Z, Thomas SA (2006). Nevirapine uptake into the central nervous system of the Guinea pig: an in situ brain perfusion study. J Pharmacol Exp Ther 317: 746–751.
   PubMed Web of Science ®Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.
   PubMed Web of Science ®Google Scholar
• Grant I (2008). Neurocognitive disturbances in HIV. Int Rev Psychiatry 20: 33–47.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231–51.
   PubMedGoogle Scholar
• Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, Street A, Lloyd J, Williams B (2005). Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry 39: 826–832.
   PubMed Web of Science ®Google Scholar
• Langford TD, Letendre SL, Larrea GJ, Masliah E (2003). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 13: 195–210.
   PubMed Web of Science ®Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, for the CHARTER Group (2008). Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System. Arch Neurol 65: 65–70.
   PubMed Web of Science ®Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65–70.
   PubMed Web of Science ®Google Scholar
• Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14: 69–74.
   PubMed Web of Science ®Google Scholar
• Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42: 963–972.
   PubMed Web of Science ®Google Scholar
• Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20: 879–887.
   PubMed Web of Science ®Google Scholar
• Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ (2001). The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27: 326–335.
   PubMed Web of Science ®Google Scholar
• Morgello S, Holzer CE 3rd, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ (2006). Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res 15: 131–138.
   PubMed Web of Science ®Google Scholar
• Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K (2002). Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 126: 182–190.
   PubMed Web of Science ®Google Scholar
• Price RW, Spudich S (2008). Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 197 (Suppl 3): S294–S306.
   Google Scholar
• Thomas SA (2004). Anti-HIV drug distribution to the central nervous system. Curr Pharm Des 10: 1313–24.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D (1991). Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 159: 645–53, 658.
   PubMed Web of Science ®Google Scholar
• Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26: 759–778.
   PubMed Web of Science ®Google Scholar